Work

Role of structural MRI in Alzheimer's disease

Year: 2010
Type: article
Abstract: Atrophy measured on structural magnetic resonance imaging (sMRI) is a powerful biomarker of the stage and intensity of the neurodegenerative aspect of Alzheimer's disease (AD) pathology. In this review, we will discuss the role of sMRI as an AD biomarker by summarizing (a) the most commonly used methods to extract information from sMRI images, (b) the different roles in which sMRI can be used as an AD biomarker, and (c) comparisons of sMRI with other major AD biomarkers.
Institution: Mayo Clinic
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,290
OpenAlex ID: W1987909254
FWCI: 2.412
Cites: 85
Cited by: 317
Related to: 9